These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 7935587)

  • 1. Incidence of cryptococcosis in and around Chandigarh, India, during the period 1982-91.
    Chander J; Sapra RK; Talwar P
    Mycoses; 1994; 37(1-2):23-6. PubMed ID: 7935587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cryptococcus neoformans, Cryptococcus gattii: serotypes in Venezuela.
    Pérez C; Dolande M; Moya M; Roselló A; de Capriles CR; Landaeta ME; Mata-Essayag S
    Mycopathologia; 2008 Sep; 166(3):149-53. PubMed ID: 18512129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular epidemiology and in vitro antifungal susceptibility testing of 108 clinical Cryptococcus neoformans sensu lato and Cryptococcus gattii sensu lato isolates from Denmark.
    Hagen F; Hare Jensen R; Meis JF; Arendrup MC
    Mycoses; 2016 Sep; 59(9):576-84. PubMed ID: 27061834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Follow-up of epidemiological data of cryptococcosis in Austria, Germany and Switzerland with special focus on the characterization of clinical isolates.
    Tintelnot K; Lemmer K; Losert H; Schär G; Polak A
    Mycoses; 2004 Dec; 47(11-12):455-64. PubMed ID: 15601449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Characterization and Antifungal Susceptibility Testing of Sequentially Obtained Clinical Cryptococcus deneoformans and Cryptococcus neoformans Isolates from Ljubljana, Slovenia.
    Tomazin R; Matos T; Meis JF; Hagen F
    Mycopathologia; 2018 Apr; 183(2):371-380. PubMed ID: 29064061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cryptococcosis in Colombia: results of the national surveillance program for the years 2006-2010.
    Escandón P; de Bedout C; Lizarazo J; Agudelo CI; Tobón A; Bello S; Restrepo A; Castañeda E;
    Biomedica; 2012 Sep; 32(3):386-98. PubMed ID: 23715187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular typing and in vitro antifungal susceptibility of Cryptococcus spp from patients in Midwest Brazil.
    Favalessa OC; de Paula DA; Dutra V; Nakazato L; Tadano T; Lazera Mdos S; Wanke B; Trilles L; Walderez Szeszs M; Silva D; Hahn RC
    J Infect Dev Ctries; 2014 Aug; 8(8):1037-43. PubMed ID: 25116671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current scenario of cryptococcosis and antifungal susceptibility pattern in India: a cause for reappraisal.
    Capoor MR; Mandal P; Deb M; Aggarwal P; Banerjee U
    Mycoses; 2008 May; 51(3):258-65. PubMed ID: 18399907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infections due to non-neoformans cryptococcal species.
    McCurdy LH; Morrow JD
    Compr Ther; 2003; 29(2-3):95-101. PubMed ID: 14606338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antifungal susceptibility of clinical and environmental Cryptococcus neoformans and Cryptococcus gattii isolates in Jabalpur, a city of Madhya Pradesh in Central India.
    Gutch RS; Nawange SR; Singh SM; Yadu R; Tiwari A; Gumasta R; Kavishwar A
    Braz J Microbiol; 2015; 46(4):1125-33. PubMed ID: 26691471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics and specificities of Cryptococcus infections in French Guiana, 1998-2008.
    Debourgogne A; Iriart X; Blanchet D; Veron V; Boukhari R; Nacher M; Carme B; Aznar C
    Med Mycol; 2011 Nov; 49(8):864-71. PubMed ID: 21612563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular characterization and antifungal susceptibility of Cryptococcus neoformans strains collected from a single institution in Lima, Peru.
    Bejar V; Tello M; García R; Guevara JM; Gonzales S; Vergaray G; Valencia E; Abanto E; Ortega-Loayza AG; Hagen F; Gutierrez EL
    Rev Iberoam Micol; 2015; 32(2):88-92. PubMed ID: 25556051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotypes and mating types of clinical strains of Cryptococcus neoformans isolated in Taiwan.
    Hsu MM; Chang JC; Yokoyama K; Nishimura K; Miyaji M
    Mycopathologia; 1994 Feb; 125(2):77-81. PubMed ID: 8028646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular typing and antifungal susceptibility of clinical and environmental Cryptococcus neoformans species complex isolates in Goiania, Brazil.
    Souza LK; Souza Junior AH; Costa CR; Faganello J; Vainstein MH; Chagas AL; Souza AC; Silva MR
    Mycoses; 2010 Jan; 53(1):62-7. PubMed ID: 19500261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microbiological characteristics of clinical isolates of Cryptococcus neoformans in Taiwan: serotypes, mating types, molecular types, virulence factors, and antifungal susceptibility.
    Liaw SJ; Wu HC; Hsueh PR
    Clin Microbiol Infect; 2010 Jun; 16(6):696-703. PubMed ID: 19694765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Invasive fungal infection by Cryptococcus neoformans var. grubii with bone marrow and meningeal involvement in a HIV-infected patient: a case report.
    Vechi HT; Theodoro RC; de Oliveira AL; Gomes RMODS; Soares RDA; Freire MG; Bay MB
    BMC Infect Dis; 2019 Mar; 19(1):220. PubMed ID: 30832607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiological, Clinical and Outcome Aspects of Patients with Cryptococcosis Caused by Cryptococcus gattii from a Non-endemic Area of Brazil.
    Damasceno-Escoura AH; de Souza ML; de Oliveira Nunes F; Pardi TC; Gazotto FC; Florentino DH; Mora DJ; Silva-Vergara ML
    Mycopathologia; 2019 Feb; 184(1):65-71. PubMed ID: 30415450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Disseminated cryptococcosis in patients with AIDS. Clinical, microbiological, and immunological analysis of 51 patients].
    Metta HA; Corti ME; Negroni R; Helou S; Arechavala A; Soto I; Villafañe MF; Muzzio E; Castello T; Esquivel P; Trione N
    Rev Argent Microbiol; 2002; 34(3):117-23. PubMed ID: 12415893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular analysis of 311 Cryptococcus neoformans isolates from a 30-month ECMM survey of cryptococcosis in Europe.
    Viviani MA; Cogliati M; Esposto MC; Lemmer K; Tintelnot K; Colom Valiente MF; Swinne D; Velegraki A; Velho R;
    FEMS Yeast Res; 2006 Jun; 6(4):614-9. PubMed ID: 16696657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular epidemiology and antifungal susceptibility of Serbian Cryptococcus neoformans isolates.
    Arsic Arsenijevic V; Pekmezovic MG; Meis JF; Hagen F
    Mycoses; 2014 Jun; 57(6):380-7. PubMed ID: 24438323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.